<DOC>
	<DOCNO>NCT00516451</DOCNO>
	<brief_summary>The purpose clinical study identify maximum tolerate dose ( MTD ) BMS-690514 daily orally Japanese subject advance metastatic solid tumor .</brief_summary>
	<brief_title>Phase I Study BMS-690514 Japanese Patients With Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Subjects advance metastatic solid tumor standard care ineffective inappropriate , adequate kidney , liver cardiac function .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>